Tel Aviv, Israel, September 12, 2022 (GLOBE NEWSWIRE) — Medigus Ltd. MDGSa technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle (“EV”) and charging solutions, announced today that Polyrizon Ltd. (“Polyrizon”), a privately held company in which Medigus owns 37.03%, has filed a PCT (Patent Cooperation Treaty) application following a filing with the United States Patent and Trademark Office for its innovative technology.
The patent relates to Polyrizon’s Capture and Contain (C&C™) platform. The C&C™ platform is based on a natural 3-D polymer network that is tailored to optimally adhere to the nasal mucosal surface. The polymeric network creates a physical barrier that traps and contains biological threats to block their entry. The C&C™ platform can be easily customized for a variety of applications to protect the human body from airborne threats such as allergens, viruses and molds.
Polyrizon is a biotechnology company focused on the development and commercialization of innovative intranasal products.
About Medigus
Medigus Ltd. based in Israel MDGS is a technology company focused on innovative growth partnerships primarily in the areas of advanced medical solutions, digital commerce and electric vehicle markets. Medigus’ medical solutions affiliations include equity interest in Polyrizon Ltd. and its stake in Industry 4.0 company ScoutCam Inc. The Company’s digital commerce subsidiaries include Gix Internet Ltd., Jeffs’ Brands Ltd. and Eventer Technologies Ltd. in the electric vehicle market are also Charging Robotics Ltd. and Revoltz Ltd. Part of the company’s portfolio of technology solution providers. To learn more about Medigus’ advanced technologies, please visit http://www.medigus.com/.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 and other state…
Read full story here https://www.benzinga.com/pressreleases/22/09/g28829094/medigus-polyrizon-submitted-an-international-patent-application-for-its-platform-technologies